Pfizer joins drug troubles
362559
Drug investors may be wishing they could pop two pills and feel better in the morning. The latest headache hit last week when Pfizer joined the rash of drug companies announcing problems with their products.
688076
Because of PfizerÂs failed trial, drugs similar to torcetrapib from other companies could face greater scrutiny Â and delays Â in getting to market.
570428
Concern over the recently publicized risks of drugs such as Vioxx and Celebrex has left doctors and patients with difficult choices.
217275
In the cold, calculating world of Wall Street, that&#39;s how the unfolding drama of new test results on old drugs is playing out, as analysts see bright spots for Pfizer (PFE:NYSE - news - research) amid other drugs&#39; woes.
51892
The withdrawal of Vioxx by competitor Merck has given Pfizer&#39;s two top arthritis drugs a huge share of the world market. But some of the same issues that forced the Vioxx withdrawal still swirl around Pfizer&#39;s Celebrex and Bextra.
402524
New York - Pfizer, the world&#39;s largest drug maker, is discussing with US regulators whether to add a stronger warning to its Bextra painkiller about rare, serious skin reactions.
561495
Dec. 19--Pfizer, the world&#39;s biggest drug maker, and the rest of the pharmaceutical sector will come under renewed pressure this week after the Food and Drug Administration (FDA) warned doctors to consider
69906
Many patients on the cholesterol drug are switching to a cheaper alternative, but Pfizer is not letting its flagship product go down without a fight.
48973
The spotlight is likely to be on Pfizer on Wednesday when federal drug regulators begin hearings on cox-2 drugs, the medicines that include Celebrex and Bextra.
101354
A day after Whitehouse Station-based Merck abruptly withdrew from the market Vioxx, its blockbuster arthritis drug, Pfizer yesterday moved to promote Celebrex, its competing medicine.
722145
Will Pfizer be able to offset the looming loss of Lipitor?
178276
In an announcement that many doctors were waiting for, Pfizer Inc. said its top-selling painkiller Celebrex -- which is similar to Vioxx -- caused an increased risk of heart attacks when used in high doses during a clinical trial.
306400
Less than a week after two sets of new data raised questions about the cardiovascular safety of two widely used painkillers, the Pfizer Inc.
259614
NEW YORK - Shares of pharmaceutical company Pfizer Inc. fell sharply in early trading after the firm reported an increased risk of heart disease for patients taking its Celebrex painkiller and arthritis drug.
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
80575
Drugmaker Pfizer Inc. is in talks with  regulators over a likely change to arthritis drug Bextra's  label to carry the strictest possible warning alerting doctors  of the risk of a potentially deadly skin reaction, the company  said in a regulatory filing.
701173
Pfizer Inc , the world&#39;s largest  drug maker, said on Friday it is in talks with investors about  spinning off its Japanese research and development laboratory,  albeit as a much smaller organization.